Mesa Laboratories, Inc.MLABNASDAQ
Loading
Year-over-year research & development expense growth
Percentile
P44
Within normal range
vs 5Y Ago
0x
Contraction
Streak
1 qtr
Consecutive declineDecelerating
| Period | Value |
|---|---|
| Q4 2025 | -0.38% |
| Q3 2025 | 1.28% |
| Q2 2025 | -2.20% |
| Q1 2025 | 0.85% |
| Q4 2024 | 9.04% |
| Q3 2024 | -2.13% |
| Q2 2024 | -8.98% |
| Q1 2024 | 21.15% |
| Q4 2023 | -14.00% |
| Q3 2023 | 3.78% |
| Q2 2023 | -3.86% |
| Q1 2023 | 4.32% |
| Q4 2022 | -3.85% |
| Q3 2022 | -12.47% |
| Q2 2022 | 10.06% |
| Q1 2022 | 0.29% |
| Q4 2021 | 97.63% |
| Q3 2021 | -7.04% |
| Q2 2021 | 5.16% |
| Q1 2021 | -1.18% |
| Q4 2020 | 12.05% |
| Q3 2020 | -7.01% |
| Q2 2020 | 12.33% |
| Q1 2020 | 9.53% |
| Q4 2019 | 130.60% |
| Q3 2019 | -10.21% |
| Q2 2019 | 5.38% |
| Q1 2019 | 12.44% |
| Q4 2018 | 2.14% |
| Q3 2018 | 0.60% |
| Q2 2018 | 11.75% |
| Q1 2018 | -0.40% |
| Q4 2017 | -15.03% |
| Q3 2017 | -23.24% |
| Q2 2017 | -5.18% |
| Q1 2017 | 41.23% |
| Q4 2016 | -17.61% |
| Q3 2016 | 0.97% |
| Q2 2016 | -0.77% |
| Q1 2016 | 6.97% |